TABLE 2. 1H NMR Spectra of the Compounds Synthesized
Compound
Chemical shifts, δ, ppm (SSCC, J, Hz)
2
2.60 (3H, s, CH3-3); 7.32 (1H, t, J = 7.6, H-4'); 7.52 (2H, t, J = 7.8, H-3', 5');
8.18 (2H, d, J = 8.1, H-2', 6'); 8.65 (1H, s, H-4); 10.17 (1H, s, CH=O)
3
2.62 (3H, s, CH3-3); 7.26 (1H, t, J = 7.9, H-4'); 7.53 (2H, t, J = 8.1, H-3', 5');
8.31 (2H, d, J = 8.2, H-2', 6'); 8.94 (1H, s, H-4); 10.12 (1H, s, CH=O)
5c
2.36 (3H, s, CH3-4''); 2.58 (3H, s, CH3-3); 7.14-7.32 (5H, m, HAr); 7.50 (2H, t,
J = 7.8, H-3', 5'); 8.21 (2H, d, J = 7.8, H-2', 6'); 8.62 (1H, s, 5-CH=);
8,78 (1H, s, H-4)
5f
2.26 (3H, s, CH3-4''); 2.28 (3H, s, CH3-3''); 2.59 (3H, s, CH3-3);
6.94-7.30 (3H, m, HAr); 7.50 (2H, t, J = 7.8, H-3', 5'); 8.21 (2H, d, J = 7.5, H-2', 6');
8.62 (1H, s, 5-CH=); 8.77 (1H, s, H-4)
6a
6b
6c
6d
6e
2.64 (3H, s, CH3-3); 7.22 (1H, t, J = 7.8, H-4'); 7.46-7.62 (5H, m, HAr);
8.18 (2H, d, J = 7.8, H-2'', 6''); 8.45 (2H, d, J = 8.1, H-2', 6'); 8.80 (1H, s, H-4);
9.37 (1H, s, H-5)
2.63 (3H, s, CH3-3); 7.22 (1H, t, J = 7.6, H-4'); 7.52 (2H, t, J = 7.8, H-3', 5');
7.62 (2H, d, J = 8.7, H-3'', 5''); 8.20 (2H, d, J = 8.7, H-2'', 6'');
8.44 (2H, d, J = 7.8, H-2', 6'); 8.76 (1H, s, H-4); 9.36 (1H, s, H-5)
2.47 (3H, s, CH3-4''); 2.65 (3H, s, CH3-3); 7.21 (1H, t, J = 7.5, H-4');
7.39 (2H, d, J = 8.7, H-3'', 5''); 7.53 (2H, t, J = 7.8, H-3', 5'); 8.05 (2H, d,
J = 8.7, H-2'', 6''); 8.46 (2H, d, J = 8.1, H-2', 6'); 8.80 (1H, s, H-4); 9.31 (1H, s, H-5)
2.64 (3H, s, CH3-3); 3.92 (3H, s, OCH3-3''); 7.01 (2H, d, J = 8.1, H-4'');
7.22 (1H, t, J = 7.6, H-4'); 7.51-7.75 (5H, m, HAr); 8.47 (2H, d, J = 7.8, H-2', 6');
8.78 (1H, s, H-4); 9.38 (1H, s, H-5)
2.65 (3H, s, CH3-3); 3.87 (3H, s, OCH3-4''); 7.12 (2H, d, J = 9.0, H-3'', 5'');
7.22 (1H, t, J = 7.6, H-4'); 7.52 (2H, t, J = 7.8, H-3', 5');
8.08 (2H, d, J = 9.0, H-2'', 6''); 8.46 (2H, t, J = 8.4, H-2', 6'); 8.77 (1H, s, H-4);
9.24 (1H, s, H-5)
6f
7
2.31 (3H, s, CH3-4''); 2.36 (3H, s, CH3-3''); 2.64 (3H, s, CH3-3); 7.26 (1H, t, J = 7.8,
H-4'); 7.37 (1H, d, J = 8.4, H-5''); 7.56 (2H, d, J = 7.8, H-3', 5'); 7.89 (1H, d, J = 8.4,
H-6''); 7.99 (1H, s, H-2''); 8.43 (2H, d, J = 8.4, H-2', 6'); 8.89 (1H, s, H-4);
9.37 (1H, s, H-5)
2.37 (3H, s, CH3-4''); 2.67 (3H, s, CH3-3); 7.20-7.36 (5H, m, HAr); 7.54 (2H, t,
J = 7.9, H-3', 5'); 8.19 (2H, d, J = 8.1, H-2', 6'); 8.88 (1H, s, H-4); 8.96 (1H, s, 5-CH=)
6-Azido-3-methyl-1-phenylpyrazolo[3,4-b]pyridine-5-carbaldehyde (2). NaN3 (2.58 g, 40 mmol) and
Bu4N+I- (1.48 g, 4 mmol) were added to a solution of aldehyde 1 (9.0 g, 33 mmol) in DMSO (45 ml) and the
mixture was stirred at 50°C for 8 h. The reaction mixture was poured into ice water, the precipitate was filtered
off, dried, and crystallized. IR spectrum, ν, cm-1: 1700 (C=O), 2120 (N3).
3-Methyl-1-phenyl-1H-pyrazolo[3,4-e][1,2,3,4]tetrazolo[1,5-a]pyridine-5-carbaldehyde
(3).
A
suspension of the azidoaldehyde 2 (0.280 g, 1mmol) in toluene (15 ml) was refluxed for 6 h. After cooling the
reaction mixture the solid was filtered off and crystallized. IR spectrum, ν, cm-1: 1635 (C=C).
N-(p-Tolyl)-6-azido-3-methyl-1-phenylpyrazolo[3,4-b]pyridine-5-carbaldimine (5c). p-Toluidine
(0.26 g, 2.4 mmol) was added to a suspension of azidoaldehyde 2 (0.56 g, 2 mmol) in ethanol (15 ml) and the
mixture was refluxed for 4 h. After cooling the reaction mixture the solid was filtered off and crystallized.
Compound 5f was prepared analogously.
6-Aryl-3-methyl-1-phenyl-1,6-dihydrodipyrazolo[3,4-b:4,3-e]pyridines, 6a-f. An arylamine (4a-f, 2.4
mmol) was added to a suspension of azidoaldehyde 2 (2 mmol) in ethanol (30 ml) and the mixture was refluxed
for 4 h. The ethanol was then evaporated , toluene (25 ml) was added to the residue, and the mixture was
refluxed again for 6 h. The reaction mixture was cooled, the solid was filtered off and crystallized.
N-(p-Tolyl)-6-chloro-3-methyl-1-phenyl[3,4-b]pyridine-5-carbaldimine (7). p-Toluidine (0.21 g,
2 mmol) was added to a suspension of the chloroaldehyde 1 (0.54 g, 2 mmol) in ethanol (25 ml) and the mixture
was refluxed for 4 h. The precipitate was filtered and crystallized.
1488